论文部分内容阅读
上海瀛科隆医药开发有限公司作为日本瀛科隆集团全资子公司,于2004年成立于上海,主要从事药物(Ⅰ至Ⅳ期),医疗器械的临床试验服务及注册申报,临床监查,生物等效性研究,国际多中心临床试验,市场调研和产品开发战略咨询,受试者招募,CRC等服务。公司成立至今,专业致力于临床试验事业,先后为70余家海内外制药企业策划并实施了152项临床试验项目;与国内200多家GCP临床医院建立了稳固、良好的合作关系。总部设
Shanghai Ying Cologne Pharmaceutical Development Co., Ltd., a wholly-owned subsidiary of Japan Ying Kelong Group, was established in Shanghai in 2004 and mainly engaged in the research and development of pharmaceuticals (Ⅰ to Ⅳ), clinical trial services of medical devices and registration declaration, clinical monitoring, biology, etc. Effectiveness studies, international multi-center clinical trials, market research and product development strategy consulting, subject recruitment, CRC and other services. Since its establishment, the company is devoted to clinical trial. It has planned and implemented 152 clinical trial projects for more than 70 domestic and overseas pharmaceutical companies. It has established a solid and good cooperative relationship with over 200 domestic GCP clinical hospitals. Headquarters